COMMUNIQUÉ DE PRESSE publié le 01/02/2024 à 13:35, il y a 2 années 5 mois Corporate Update on Clinical Evaluation of MedMira’s Products MedMira Inc. provides update on Health Canada review process for maternity screening, highlighting increasing need due to rising syphilis infection rates. Company's syphilis test performance shows promising results for infectious case detection and maternity screening MedMira Inc. Health Canada Review Maternity Screening Syphilis Infection Rates Test Performance
COMMUNIQUÉ DE PRESSE publié le 30/12/2023 à 05:00, il y a 2 années 6 mois MedMira Reports First Quarter Results FY2024 MedMira Inc. (TSXV:MIR) has reported its financial results for the quarter ended October 31, 2023. The company achieved significant milestones during this period, including receiving US FDA 510(k) clearance for the HIV-2 claim on its Reveal® G4 Rapid HIV 1/2 antibody test. This approval positions MedMira as a key player in the HIV testing market and allows the company to expand its market share and revenue in the United States.
COMMUNIQUÉ DE PRESSE publié le 14/12/2023 à 04:30, il y a 2 années 7 mois U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
COMMUNIQUÉ DE PRESSE publié le 29/11/2023 à 05:00, il y a 2 années 7 mois MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 04:00, il y a 2 années 9 mois Update on MedMira’s Regulatory Path in Canada and the USA
COMMUNIQUÉ DE PRESSE publié le 31/08/2023 à 04:00, il y a 2 années 10 mois Progress Update on Securities
COMMUNIQUÉ DE PRESSE publié le 30/06/2023 à 04:00, il y a 3 années MedMira Reports Third Quarter Results FY2023
COMMUNIQUÉ DE PRESSE publié le 04/04/2023 à 03:00, il y a 3 années 3 mois MedMira Reports Second Quarter Results FY2023
COMMUNIQUÉ DE PRESSE publié le 14/03/2023 à 21:31, il y a 3 années 3 mois Update on MedMira’s Reveal TP (Syphilis) Clinical Trials in Canada
COMMUNIQUÉ DE PRESSE publié le 20/02/2023 à 23:00, il y a 3 années 4 mois MedMira Enters into Partnership with Maternova for USA and Latin America
Publié le 13/07/2026 à 18:00, il y a 17 heures 6 minutes CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Publié le 13/07/2026 à 18:00, il y a 17 heures 6 minutes PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Publié le 13/07/2026 à 18:00, il y a 17 heures 6 minutes THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Publié le 14/07/2026 à 01:45, il y a 9 heures 21 minutes Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Publié le 14/07/2026 à 00:01, il y a 11 heures 5 minutes Captor Capital Announces Delay in its Annual Filings
Publié le 13/07/2026 à 23:10, il y a 11 heures 56 minutes Galaxy Ventures Inc. Announces Director Resignation
Publié le 13/07/2026 à 21:35, il y a 13 heures 31 minutes ATHA Energy Announces Corporate Activities Update
Publié le 13/07/2026 à 20:00, il y a 15 heures 6 minutes IBC Announces Share-Based Compensation to Directors
Publié le 14/07/2026 à 10:58, il y a 8 minutes EQS-Adhoc: Semperit AG Holding: Operating earnings in Q2 2026 significantly above the prior-year figure; full-year earnings forecast raised
Publié le 14/07/2026 à 10:34, il y a 32 minutes Original-Research: Vossloh AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Publié le 14/07/2026 à 10:30, il y a 36 minutes Thailand Advances Net Zero 2050 through Public–Private 'ONE MIND' Collaboration TCMA Launches 'The NEXT Chapter' to Position Industry as a Climate Solution Partner
Publié le 14/07/2026 à 10:10, il y a 56 minutes FocalPoint and STMicroelectronics enter into a commercial agreement to deliver enhanced GNSS reliability for automotive applications
Publié le 14/07/2026 à 10:05, il y a 1 heure 1 minute Quantinuum, Rolls-Royce, Riverlane and University of Edinburgh Sign Agreement to Explore Quantum Computing for Industrial Design and Simulation